A commodity appears at first sight an extremely obvious, trivial thing. But its analysis brings out that it is a very strange thing, abounding in metaphysical subtleties and theological niceties.
During the first great wave of capitalism,
Karl Marx was perplexed by how commodification transformed everything it touched like King Midas, giving otherwise ordinary goods magical qualities.
Today we emerge from stealth with a proposal for reimagining how venture capital can foster the sustainable emergence of psychedelics. We also share some announcements of the actions that we’re taking towards that future.
Dive in conversation with the brilliant minds exploring the psychedelic and life sciences fields.
Our guests Ronan Levy (Field Trip Health) and Sanjay Singhal (Nikean Foundation) share their perspectives on the science of psychedelics, what future models of psychedelic care will look like, and their philosophy on how the space is evolving.
Joined by Paul Austin (Third Wave), Ken Jordan (Lucid News), and Annie Oak (Lucid News), we dive into what it takes to build a media platform in the psychedelics space and how to craft the ongoing psychedelic narrative.
Our guests David Champion (Maya Health), Jero Beccar (Hyka), and Lucia Huang (Osmind) highlight the technology platforms they’re building to expand access to high-quality psychedelic therapy.
Guests Nanea Reeves and Mani Srinivasan (TRIPP) expand our perspectives on what “reality” really is, outlining the story of VR-based mindfulness app TRIPP and their vision for an XR-enabled future. We discuss the similarities between a psychedelic trip and a VR trip, and the connection between the two worlds. Listen for a glimpse into the future.